CellaVision AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLVSF research report →
About the company
CellaVision AB (publ), a company established in Lund, Sweden, in 1994, specializes in the development and distribution of digital analytical solutions for blood and body fluid samples. Their offerings cater to the healthcare services sector, with a significant global presence spanning Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific region. The company's product portfolio includes advanced hardware such as the CellaVision DM1200 and CellaVision DM9600, which are designed to automatically capture digital images from blood smears and various body fluid preparations, alongside the CellaVision DC-1 analyzer.
- CEO
- Simon Ostergaard
- IPO
- 2013
- Employees
- 228
- HQ
- Lund, SE
Price Chart
- Market Cap
- $333.92M
- P/E
- 26.05
- P/S
- 4.78
- P/B
- 3.82
- EV/EBITDA
- 15.27
- Div Yield
- 1.88%
- Gross Margin
- 67.98%
- Op Margin
- 23.74%
- Net Margin
- 18.35%
- ROE
- 15.43%
- ROIC
- 13.35%
- Revenue
- $758.97M · 4.94%
- Net Income
- $153.08M · 8.78%
- EPS
- $6.42 · 8.81%
- Op Income
- $202.07M
- FCF YoY
- -5.33%
- 52W High
- $19.28
- 52W Low
- $13.49
- 50D MA
- $13.62
- 200D MA
- $16.22
- Beta
- 0.96
- Avg Volume
- 34
Get TickerSpark's AI analysis on CLVSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CLVSF coverage
Recent articles, reports, and earnings notes.
No research on CLVSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLVSF report →Similar companies
Peers in the same neighborhood.